Ashland Specialty Ingredients, a business unit of Ashland Inc., is a highly respected supplier of pharmaceutical-grade cellulose-derived and vinyl pyrrolidone-based polymeric excipients, solubilizers and tablet film coating systems to enable the delivery of active pharmaceutical ingredients. Ashland products are supported by global research and development scientists and highly trained sales teams with expertise in oral solid-dosage formulation techniques and current drug-delivery challenges, including drug solubilization and bioavailability enhancement, controlled-release formulations, tablet binding and disintegration. Visit us: http://www.ashland.com.
Aptalis Pharmaceutical Technologies is focused on developing high-value products with robust, defensible proprietary positions that grow the commercial value of our partners’ portfolios. We develop and manufacture enhanced pharmaceutical products based on our broad range of proprietary oral drug delivery platforms, including: 1) Taste masking and ODTs 2) Customized drug release 3) Bioavailability enhancement We utilize these technologies to develop novel prescription and OTC products that have advantages over existing products and address unmet medical needs. Our integrated R&D and manufacturing teams in the U.S. and Europe work with our partners from formulation through scale-up and commercial-scale manufacturing. Since 2009, our partners have commercialized more than 40 products worldwide. We have a variety of products available for licensing across multiple therapeutic categories and collaborate with our partners to develop customized, value-added Rx and OTC products. To learn more speak with one of our licensing representatives, or visit: http://www.aptalispharmaceuticaltechnologies.com.
Colorcon is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Our best-in-class products and technologies are complemented by our value-added services, which support all phases of solid oral dose design and development. Visit us: http://www.colorcon.com/.
NETZSCH Premier Technologies is the North American subsidiary of the globally-operated group of NETZSCH companies. For over 140 years, NETZSCH has been a global leader in particle reduction equipment. On exhibit will be NETZSCH Vita mills and mixers which utilize energy efficient, high recirculation technology to achieve excellent repeatability as well as homogeneous dispersion. The DeltaVita®, a horizontal bead mill can be customized for each application. Units are available for ultra-fine dispersion and grinding down into the micron- to nano-scale range. KappaVita homogenizing mixers offer integrated CIP/SIP design and can process highly viscous substances. Both are offered for aseptic processing. Visit us: http://www.netzsch.com/gd.
Sirius Analytical offers instrumentation and services for pKa, logP/logD, Solubility, Dissolution and Particle Size/Shape analysis including detailed studies of Solubility, Supersaturation and Dissolution. Our unique solutions for supersaturation measurement reveal insights about the pH-dependent supersaturation a compound can exhibit and how it may be enhanced or suppressed via additives and excipients. Our expertise in automation means data is obtained at early stages of pre-formulation and development, improving efficiency and allowing informed decisions to be made earlier in the drug development process. Our new inForm instrument provides automated biorelevant solubility, dissolution and lipolysis testing of both API and final dosage forms. Visit us: http://www.sirius-analytical.com/.
Quotient Clinical offers a unique range of services, based on its Translational Pharmaceutics™ platform. Translational Pharmaceutics™ integrates formulation development, real-time GMP manufacturing with clinical testing, significantly reducing the time and cost of bringing a drug to market. For more than 20 years, Quotient Clinical has brought innovation to early drug development programs for pharmaceutical companies worldwide. At the company’s purpose built facilities, “real-time” manufacturing of all types of dosage forms is co-located with its clinical pharmacology unit to maximize flexibility, speed and cost savings for clients. More than 200 highly trained specialists provide a full range of services from study set-up right through to data analysis and reporting. Visit us: http://www.quotientclinical.com.